Absorbable PGLA Surgical Sutures Market (2026 - 2036)

Absorbable PGLA Surgical Sutures Market Size, Market Forecast and Outlook By FMI

The absorbable PGLA surgical sutures market was valued at USD 213.40 million in 2025, projected to reach USD 223.22 million in 2026, and is forecast to expand to USD 349.98 million by 2036 at a 4.6% CAGR. As per FMI, the polyglactin-based suture segment maintains its clinical relevance through a differentiated absorption profile that fills a specific wound closure timeline niche between fast-absorbing gut sutures and slow-absorbing polydioxanone alternatives. Hospital formulary managers continue to specify PGLA sutures for soft tissue approximation where 60 to 90 day tensile strength retention is the clinical standard.

Summary of Absorbable PGLA Surgical Sutures Market

• Market Snapshot
  • The absorbable PGLA surgical sutures market is valued at USD 213.40 million in 2025 and is projected to reach USD 349.98 million by 2036.
  • The industry is expected to grow at a 4.6% CAGR from 2026 to 2036, creating an incremental opportunity of USD 126.76 million.
  • The market is a clinical-specification-driven consumable category where suture absorption timeline, tensile strength retention, and hospital formulary standardization define competitive positioning.
• Demand and Growth Drivers
  • Demand is rising as global surgical procedure volumes increase and ambulatory surgical centers standardize on absorbable wound closure materials to reduce patient follow-up requirements.
  • Antibacterial-coated PGLA variants are gaining traction in infection-sensitive surgical settings as hospital infection prevention committees tighten suture specification protocols.
  • Growth is further supported by the distinct 60 to 90 day absorption profile of PGLA sutures that fills a clinical niche between fast-absorbing and slow-absorbing alternatives.
  • Among key countries, India leads at 5.8% CAGR, followed by Germany at 5.3%, Brazil at 4.8%, the USA at 4.4%, the UK at 3.9%, and Japan at 3.5%.
• Product and Segment View
  • The market includes monofilament, braided, and specialty configuration polyglactin sutures used across general surgery, obstetrics and gynecology, urology, cardiovascular surgery, and orthopedic surgery.
  • Monofilament sutures lead by type with 53.0% share in 2026, driven by reduced tissue drag and consistent tensile strength retention.
  • General surgery leads by application with 46.0% share in 2026.
  • Hospitals lead by end user, supported by the high-volume surgical consumption of absorbable sutures across inpatient departments.
  • The scope includes all absorbable surgical sutures manufactured from polyglactin (PGLA) copolymer, while excluding PGA, polydioxanone, gut, and non-absorbable sutures.
• Geography and Competitive Outlook
  • India and Germany are the fastest-growing markets due to surgical infrastructure expansion and wound closure protocol standardization, while the United States remains the largest single-country market.
  • Competition is shaped by suture coating technology, absorption timeline consistency, and group purchasing organization contract positioning, with key players including Johnson & Johnson, Ethicon LLC, Medtronic, B. Braun, and Peters Surgical.
  • Based on FMI's report, the market is consolidating around manufacturers with full absorbable suture portfolios spanning multiple polymer types and gauge sizes.
• Analyst Opinion at FMI
  • Sabyasachi Ghosh, Principal Consultant for Healthcare Consumables, opines: 'In my analysis, I have observed that PGLA suture selection is increasingly driven by formulary-level procurement decisions rather than individual surgeon choice. Hospitals that allow fragmented suture purchasing across departments face inconsistent pricing and inventory inefficiency. Supply chain directors who consolidate PGLA suture procurement under unified group purchasing contracts can achieve 12 to 18 percent cost reductions while maintaining clinical specification compliance across surgical specialties.'
• Strategic Implications / Executive Takeaways
  • Suture manufacturers must maintain comprehensive PGLA product lines across all gauge sizes and needle configurations to meet unified formulary procurement requirements from group purchasing organizations.
  • Hospital supply chain directors should consolidate PGLA suture procurement across surgical departments to achieve volume-based pricing improvements and reduce inventory carrying costs.
  • Surgical department heads must evaluate the clinical trade-offs between monofilament and braided PGLA configurations based on procedure-specific tissue tension and knot security requirements.

Absorbable PGLA Surgical Sutures Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 223.22 million
Industry Value (2036)	USD 349.98 million
CAGR (2026-2036)	4.6%

Source: Future Market Insights, 2026

The market is adding an incremental opportunity of approximately USD 126.76 million between 2026 and 2036. Growth is shaped by rising global surgical volumes, an expanding ambulatory surgical center footprint that standardizes on absorbable wound closure to eliminate patient return visits, and the gradual adoption of antibacterial-coated PGLA variants in infection-sensitive surgical settings. FMI analysts note that braided PGLA sutures continue to hold a distinct clinical niche in procedures requiring superior knot security, particularly in gynecological and urological closures where tissue tension demands multi-strand construction.

Regional growth trajectories reflect the geographic distribution of surgical infrastructure investment and wound closure material standardization. India sets the pace with a 5.8% CAGR, driven by rising surgical volumes in government hospitals under the National Health Mission and an expanding private hospital network. Germany follows at 5.3%, supported by ambulatory surgery growth and strict wound closure protocol adherence under German surgical society guidelines. Brazil registers a 4.8% pace, anchored by SUS (Unified Health System) surgical expansion in secondary and tertiary hospitals. The United States advances at 4.4%, driven by group purchasing organization formulary consolidation. The United Kingdom grows at 3.9%, while Japan registers a 3.5% trajectory supported by its aging population and rising orthopedic surgical volumes.

Absorbable PGLA Surgical Sutures Market Definition

Absorbable PGLA surgical sutures are wound closure devices manufactured from polyglactin (poly-glycolide-co-lactide) copolymer that provide temporary tissue approximation with a 60 to 90 day tensile strength retention profile before progressive hydrolysis and absorption. These sutures are available in monofilament, braided, and specialty configurations for use across general surgery, obstetrics, urology, cardiovascular surgery, and orthopedic surgery.

Absorbable PGLA Surgical Sutures Market Inclusions

Market scope includes all absorbable surgical sutures manufactured from polyglactin (PGLA) copolymer across monofilament, braided, and specialty configurations. Needle-suture combination products and standalone suture material are fully incorporated. Global and regional market sizes, forecast period metrics, and segment-level analysis across suture type, application, end user, and geography are covered.

Absorbable PGLA Surgical Sutures Market Exclusions

Absorbable sutures manufactured from polyglycolic acid (PGA), polydioxanone (PDO), or catgut are excluded. Non-absorbable sutures, surgical stapling devices, tissue adhesives, wound closure strips, and surgical mesh products fall outside the analytical scope.

Absorbable PGLA Surgical Sutures Market Research Methodology

• Primary Research: Analysts engaged with hospital materials management directors, surgical department procurement leads, and suture manufacturing quality assurance teams to map formulary review cycles and purchasing decision criteria.
• Desk Research: Data collection phases aggregated hospital surgical procedure volume databases, group purchasing organization contract announcements, and surgical society wound closure guideline publications.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of surgical procedure volumes by specialty, applying PGLA-specific suture utilization rates and regional pricing to project future revenue.
• Data Validation and Update Cycle: Projections are tested against publicly reported surgical consumables revenue from leading suture manufacturers and cross-referenced with hospital surgical volume databases.

Why is the Absorbable PGLA Surgical Sutures Market Growing?

Market expansion rests on three fundamental shifts driving adoption across surgical specialties and healthcare facilities. Healthcare modernization creates compelling advantages through PGLA suture systems that provide comprehensive wound closure with predictable absorption characteristics, enabling surgeons to achieve optimal healing outcomes while ensuring procedural efficiency and justifying investment over traditional suture methods. Surgical technique advancement accelerates as medical facilities worldwide seek reliable closure systems that deliver surgical precision directly to operative procedures, enabling improved patient outcomes that align with healthcare quality expectations and maximizes procedural efficiency. Aging population demographics drive adoption from healthcare systems requiring advanced wound closure solutions that maximize healing capacity while maintaining biocompatible performance during tissue integration and recovery operations.

Segmental Analysis

Primary Classification: The market segments by suture type into monofilament, braided, and specialty configurations, representing the evolution from basic PGLA formulations to advanced multi-component formats for comprehensive surgical applications.

Secondary Breakdown: Application segmentation divides the absorbable PGLA surgical sutures market into general surgery, obstetrics and gynecology, urology, cardiovascular surgery, orthopedic surgery, and other specialized procedures, reflecting distinct requirements for tensile strength, absorption timing, and handling characteristics.

Tertiary Classification: End-user segmentation encompasses hospitals, ambulatory surgical centers, specialty clinics, and surgical facilities, addressing varying volume requirements and procedural complexity needs.

Regional Classification: Geographic distribution covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with developed markets leading adoption while emerging economies show accelerating growth patterns driven by healthcare infrastructure development programs.

The segmentation structure reveals technology progression from standard monofilament formats toward integrated coating platforms with enhanced handling and biocompatible capabilities, while application diversity spans from routine procedures to complex surgical operations requiring comprehensive wound closure and predictable absorption solutions.

By Suture Type, the Monofilament Segment Accounts for Dominant Market Share

Monofilament segment is estimated to account for 53% of the absorbable PGLA surgical sutures market share in 2026. The segment's leading position stems from its fundamental role as a critical component in surgical applications and its extensive use across multiple general surgery and specialized procedures. Monofilament's dominance is attributed to its superior handling characteristics, including excellent knot security, reduced tissue drag, and predictable absorption timing that make it indispensable for everyday surgical operations.

Market Position: Monofilament systems command the leading position in the absorbable PGLA surgical sutures market through advanced polymer processing technologies, including comprehensive diameter control, uniform coating application, and reliable manufacturing performance that enable surgeons to deploy closure solutions across diverse surgical environments.

Value Drivers: The segment benefits from surgeon preference for proven suture profiles that provide exceptional handling without requiring premium material costs. Efficient manufacturing processes enable deployment in general surgery, specialty procedures, and minimally invasive applications where reliability and cost efficiency represent critical selection requirements.

Competitive Advantages: Monofilament systems differentiate through excellent knot-holding capacity, minimal tissue reaction, and compatibility with standard surgical instruments that enhance procedural capabilities while maintaining economical material profiles suitable for diverse surgical applications.

Key market characteristics:

• Advanced extrusion systems with precision diameter control, consistent polymer properties, and specialized coating capabilities
• Material optimization enabling comprehensive wound closure with minimal inflammatory response
• Manufacturing accessories, including packaging lines, sterilization systems, and quality control equipment for high-volume operations

By Application, the General Surgery Segment Accounts for the Largest Market Share

General surgery segment is projected to hold 46% of the absorbable PGLA surgical sutures market share in 2026. The segment's market leadership is driven by the extensive use of PGLA sutures in abdominal procedures, soft tissue repair, wound closure applications, and routine surgical operations, where bioabsorbable polymers serve as both a closure mechanism and healing facilitator. The general surgery sector's consistent demand for reliable suture materials supports the segment's dominant position.

Market Context: General surgery applications dominate the absorbable PGLA surgical sutures market due to widespread adoption of absorbable solutions and increasing focus on surgical efficiency, wound healing optimization, and patient comfort that enhance procedural outcomes while maintaining clinical standards.

Appeal Factors: Surgical teams prioritize predictable absorption, minimal tissue reaction, and compatibility with standard surgical protocols that enable coordinated deployment across multiple procedural needs. The segment benefits from substantial procedure growth and healthcare facility modernization that emphasize reliable closure systems for general surgical applications.

Growth Drivers: Hospital surgical departments incorporate PGLA sutures as standard components for abdominal procedures and tissue repair operations, while surgical efficiency initiatives increase demand for materials that comply with clinical protocols and enhance patient outcomes.

Market Challenges: Raw material cost fluctuations and absorption timing standardization may limit deployment flexibility in ultra-cost-sensitive markets or regions with varying surgical requirements.

Application dynamics include:

• Strong growth in hospital surgical departments and outpatient facilities requiring standardized suture formats
• Increasing adoption in minimally invasive procedures and advanced surgical techniques for enhanced closure
• Rising integration with surgical protocols and evidence-based practice guidelines

What are the Drivers, Restraints, and Key Trends of the Absorbable PGLA Surgical Sutures Market?

Growth Accelerators: Healthcare infrastructure expansion drives primary adoption as PGLA suture systems provide exceptional biocompatibility that enables wound closure without material removal procedures, supporting surgical efficiency and patient comfort that require reliable polymer formats. Surgical procedure growth accelerates market expansion as medical facilities seek advanced closure solutions that maintain healing optimization during recovery while enhancing procedural convenience through predictable absorption timing and tissue compatibility. Surgeon awareness increases worldwide, creating sustained demand for bioabsorbable closure systems that complement modern surgical techniques and provide clinical advantages in wound healing efficiency.

Growth Inhibitors: Raw material volatility challenges differ across polymer markets regarding price stability and supply chain consistency, which may limit margin predictability and cost planning in price-sensitive healthcare categories with demanding affordability requirements. Regulatory complexity persists regarding medical device standards and biocompatibility testing that may increase manufacturing costs in jurisdictions with strict healthcare regulatory protocols. Market fragmentation across multiple absorption timeframes and sizing standards creates compatibility concerns between different surgical protocols and existing procedural infrastructure.

Market Evolution Patterns: Adoption accelerates in general surgery and specialty procedure sectors where clinical benefits justify material investments, with geographic concentration in developed healthcare markets transitioning toward mainstream adoption in emerging economies driven by healthcare modernization and surgical facility development. Technology advancement focuses on enhanced polymer formulations, improved coating systems, and integration with minimally invasive platforms that optimize surgical performance and manufacturing consistency. The absorbable PGLA surgical sutures market could face disruption if alternative wound closure methods or regulatory changes significantly challenge traditional PGLA suture advantages in surgical applications.

Analysis of the Absorbable PGLA Surgical Sutures Market by Key Country

The absorbable PGLA surgical sutures market demonstrates varied regional dynamics with growth leaders including China (6.2% CAGR) and India (5.8% CAGR) driving expansion through healthcare modernization and surgical facility development. Steady performers encompass Germany (5.3% CAGR), Brazil (4.8% CAGR), the USA (4.4% CAGR), the UK (3.9% CAGR), and Japan (3.5% CAGR), benefiting from established healthcare systems and advanced surgical adoption.

Country	CAGR (2026-2036)
China	6.2%
India	5.8%
Germany	5.3%
Brazil	4.8%
USA	4.4%
UK	3.9%
Japan	3.5%

Source: FMI analysis based on primary research and proprietary forecasting model

Regional synthesis reveals Asia-Pacific markets leading growth through healthcare infrastructure expansion and surgical procedure development, while European countries maintain steady expansion supported by specialized applications and medical device compliance requirements. North American markets show strong growth driven by hospital demand and surgical facility upgrades.

China Drives Healthcare Infrastructure Leadership

China establishes regional leadership through rapid healthcare modernization and comprehensive surgical facility development, integrating advanced PGLA suture systems as standard components in hospital procedures and specialized medical operations. The country's 6.2% CAGR through 2036 reflects healthcare investment promoting medical infrastructure and surgical capability development that mandate the use of reliable bioabsorbable systems in medical operations. Growth concentrates in major metropolitan areas, including Beijing, Shanghai, and Guangzhou, where hospital networks showcase integrated PGLA suture systems that appeal to medical facilities seeking enhanced surgical efficiency and international healthcare standards.

Chinese manufacturers are developing innovative PGLA suture solutions that combine local production advantages with international quality specifications, including advanced coating technologies and specialized absorption capabilities.

Strategic Market Indicators:

• Healthcare infrastructure growth providing substantial support for domestic medical device development
• Hospital expansion driven by government investment and medical facility construction demand
• Surgical procedure growth for cost-effective suture solutions targeting domestic and export applications

India Demonstrates Comprehensive Healthcare Development

The Indian market emphasizes surgical applications, including rapid healthcare development and comprehensive medical facility expansion that increasingly incorporates PGLA sutures for general surgery and specialized procedures. The country is projected to show a 5.8% CAGR through 2036, driven by massive healthcare activity under medical infrastructure initiatives and hospital demand for standardized, high-quality surgical materials. Indian medical facilities prioritize cost-effectiveness with PGLA sutures delivering clinical efficiency through economical material usage and reliable performance capabilities.

Technology deployment channels include major hospitals, surgical centers, and medical device distributors that support high-volume usage for domestic and specialty applications.

Performance Metrics:

• Medical facilities in Mumbai, Delhi, and Bangalore leading PGLA suture adoption for surgical operations
• Healthcare facility compliance with medical standards, driving quality selection criteria

Germany Drives Medical Innovation Excellence

The German market emphasizes advanced PGLA suture features, including innovative polymer technologies and integration with comprehensive surgical platforms that manage general surgery, specialty procedures, and minimally invasive applications through unified closure systems. The country is projected to show a 5.3% CAGR through 2036, driven by medical facility expansion under healthcare excellence trends and hospital demand for premium, reliable surgical materials. German hospitals prioritize clinical outcomes with PGLA sutures delivering comprehensive wound closure through enhanced biocompatibility and procedural innovation.

Technology deployment channels include major medical device distributors, surgical centers, and hospital systems that support custom development for premium operations.

Performance Metrics:

• Medical facilities in Munich, Berlin, and Hamburg leading PGLA suture adoption for surgical operations
• Hospital compatibility with surgical requirements, driving specification selection criteria

Brazil Drives Emerging Market Growth

In São Paulo, Rio de Janeiro, and Brasília, Brazilian medical facilities and hospital operators are implementing advanced PGLA suture systems to enhance surgical capabilities and support clinical efficiency that aligns with healthcare protocols and procedural standards. The Brazilian market demonstrates sustained growth with a 4.8% CAGR through 2036, driven by healthcare expansion programs and medical investments that emphasize reliable surgical systems for general surgery and specialty applications. Brazilian hospitals are prioritizing PGLA suture systems that provide exceptional clinical performance while maintaining compliance with medical standards and minimizing procedural complexity, particularly important in hospital surgical departments and specialty medical operations.

Market expansion benefits from healthcare programs that mandate enhanced surgical materials in medical specifications, creating sustained demand across Brazil's hospital and specialty sectors, where wound healing and material consistency represent critical requirements.

Strategic Market Indicators:

• Hospital operators and medical facilities leading adoption with clinical programs requiring reliable surgical systems
• Healthcare standards providing framework support for high-performance material acquisition
• Quality control requirements driving demand for certified systems with clinical testing documentation
• Specialized medical segments adopting comprehensive PGLA suture solutions for surgical facilities and specialty hospitals

United States Maintains Healthcare Leadership

The USA market emphasizes advanced surgical applications, with documented clinical excellence in hospital procedures and specialty operations through integration with existing surgical protocols and quality assurance infrastructure. The country leverages medical expertise in polymer technology and surgical materials to maintain market leadership. Medical centers, including those in California, Texas, and New York, showcase advanced installations where PGLA suture systems integrate with comprehensive surgical platforms and procedural systems to optimize wound closure and clinical efficiency.

American medical facilities prioritize surgical precision and material consistency in product selection, creating demand for premium PGLA suture systems with advanced features, including specialized coatings and integration with minimally invasive protocols. The absorbable PGLA surgical sutures market benefits from established healthcare infrastructure and willingness to invest in specialized polymer technologies that provide superior clinical performance and regulatory compliance.

Market Intelligence Brief:

• Precision focus on absorption timing and handling uniformity, driving general surgery segment growth
• Technology collaboration between American medical device manufacturers and international surgical companies
• Premium surgical systems expanding PGLA suture integration in hospital and specialty applications

United Kingdom Drives Medical Excellence

The UK market demonstrates sophisticated surgical deployment, growing at 3.9% CAGR, with documented clinical excellence in hospital procedures and specialty applications through integration with existing surgical systems and healthcare infrastructure. The country leverages medical expertise in surgical materials and clinical protocols to maintain market position. Medical centers, including those in London, Manchester, and Birmingham, showcase advanced installations where PGLA suture systems integrate with comprehensive surgical platforms and quality systems to optimize procedural efficiency and clinical outcomes.

British medical facilities prioritize clinical precision and material reliability in product selection, creating demand for specialized PGLA suture systems with advanced features, including enhanced biocompatibility and integration with evidence-based protocols. The absorbable PGLA surgical sutures market benefits from established healthcare systems and focus on clinical outcomes that provide superior surgical performance and regulatory adherence.

Performance Metrics:

• Clinical focus on wound healing and absorption predictability, driving hospital segment growth
• Medical collaboration between British healthcare providers and international surgical companies
• Advanced surgical systems expanding PGLA suture adoption in hospital and specialty medical applications

Japan Maintains Quality Leadership

Japan's sophisticated medical device market demonstrates meticulous PGLA suture deployment, growing at 3.5% CAGR, with documented clinical excellence in hospital procedures and specialty applications through integration with existing surgical protocols and quality assurance infrastructure. The country leverages engineering expertise in polymer manufacturing and medical device production to maintain market leadership. Medical centers, including Tokyo, Osaka, and Nagoya, showcase advanced installations where PGLA suture systems integrate with comprehensive surgical platforms and quality systems to optimize wound closure and clinical efficiency.

Japanese medical facilities prioritize surgical precision and material consistency in product selection, creating demand for premium PGLA suture systems with advanced features, including ultra-precise manufacturing and integration with specialized surgical protocols. The absorbable PGLA surgical sutures market benefits from established medical infrastructure and willingness to invest in specialized polymer technologies that provide superior clinical properties and regulatory compliance.

Market Intelligence Brief:

• Precision focus on manufacturing quality and clinical uniformity, driving hospital segment growth
• Technology collaboration between Japanese medical device manufacturers and international surgical companies
• Premium surgical systems expanding PGLA suture integration in medical and specialty applications

Europe Market Split by Country

The absorbable PGLA surgical sutures market in Europe is projected to grow from USD 58.7 million in 2026 to USD 85.2 million by 2036, registering a CAGR of 3.8% over the forecast period. Germany is expected to maintain its leadership position with a 42.1% market share in 2026, declining slightly to 41.8% by 2036, supported by its medical device excellence and major surgical centers, including Bavaria and North Rhine-Westphalia.

France follows with a 23.6% share in 2026, projected to reach 24.1% by 2036, driven by comprehensive hospital surgical programs and medical facility initiatives. The United Kingdom holds a 18.4% share in 2026, expected to maintain 18.7% by 2036 through established healthcare sectors and surgical procedure adoption. Italy commands an 11.2% share, while Spain accounts for 3.9% in 2026. The Rest of Europe region is anticipated to gain momentum, expanding its collective share from 0.8% to 1.2% by 2036, attributed to increasing healthcare development in Eastern European countries and emerging medical programs implementing standardized surgical systems.

Competitive Landscape of the Absorbable PGLA Surgical Sutures Market

The absorbable PGLA surgical sutures market operates with moderate concentration, featuring approximately 15-20 participants, where leading companies control roughly 55-62% of the global market share through established medical distribution networks and comprehensive surgical product portfolio capabilities. Competition emphasizes absorption predictability, handling characteristics, and clinical reliability rather than premium feature rivalry.

Market leaders encompass Johnson & Johnson, Ethicon LLC, and Medtronic, which maintain competitive advantages through extensive surgical materials expertise, global medical distribution networks, and comprehensive clinical support capabilities that create surgeon loyalty and support hospital requirements. These companies leverage decades of polymer manufacturing experience and ongoing surgical technology investments to develop advanced PGLA suture systems with exceptional biocompatibility and clinical features.

Specialty challengers include B. Braun, Peters Surgical, and DemeTech, which compete through specialized surgical innovation focus and efficient manufacturing solutions that appeal to medical buyers seeking reliable performance formats and custom sizing flexibility. These companies differentiate through clinical efficiency emphasis and specialized market focus.

Market dynamics favor participants that combine consistent clinical performance with advanced manufacturing support, including sterile packaging and medical distribution capabilities. Competitive pressure intensifies as traditional medical device manufacturers expand into PGLA suture systems, while specialized surgical companies challenge established players through innovative polymer formulations and cost-effective production targeting emerging hospital segments.

Key Players in the Absorbable PGLA Surgical Sutures Market

• Johnson & Johnson
• Ethicon LLC
• Medtronic
• B. Braun
• Peters Surgical
• DemeTech
• Internacional Farmaceutica
• Teleflex Medical
• Mani
• AD Surgical
• Lotus Surgicals
• Weigao Group

Scope of the Report

Metric	Value
Quantitative Units	USD 223.22 million to USD 349.98 million, at a CAGR of 4.6%
Market Definition	Absorbable PGLA surgical sutures are wound closure devices manufactured from polyglactin copolymer providing 60 to 90 day tensile strength retention before absorption.
Suture Type Segmentation	Monofilament, Braided, Specialty Configurations
Application Segmentation	General Surgery, Obstetrics and Gynecology, Urology, Cardiovascular Surgery, Orthopedic Surgery, Others
End User Segmentation	Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Surgical Facilities
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	India, Germany, Brazil, USA, UK, Japan, and 40 plus countries
Key Companies Profiled	Johnson & Johnson, Ethicon LLC, Medtronic, B. Braun, Peters Surgical, DemeTech, Internacional Farmaceutica, Teleflex Medical, Mani, AD Surgical, Lotus Surgicals, Weigao Group
Forecast Period	2026 to 2036
Approach	Bottom-up methodology starting with surgical procedure volumes by specialty, applying PGLA-specific suture utilization rates and regional pricing.

Absorbable PGLA Surgical Sutures Market by Segments

Suture Type:

• Monofilament
• Braided
• Specialty Configurations

Application:

• General Surgery
• Obstetrics and Gynecology
• Urology
• Cardiovascular Surgery
• Orthopedic Surgery
• Others

End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Surgical Facilities

Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Nordic
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • ASEAN
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkey
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Bibliography

• World Health Organization. (2024). Global guidelines for the prevention of surgical site infection, second edition. WHO.
• USA Food and Drug Administration. (2024). Guidance document: Absorbable surgical sutures, premarket notification submissions. FDA.
• German Society of Surgery (DGCH). (2024). S3 guideline: Wound management and surgical site infection prevention. AWMF.
• National Health Service England. (2024). National tariff payment system: Surgical procedure specifications. NHS England.
• Ministry of Health and Family Welfare, Government of India. (2024). National Health Mission: Annual progress report. MoHFW.
• Organisation for Economic Co-operation and Development. (2024). Health at a glance: Surgical procedure volumes across OECD countries. OECD.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.